A novel approach to identify responder subgroups and predictors of response to low- and high-dose capsaicin patches in postherpetic neuralgia

European Journal of Pain (United Kingdom)

Volumn 17, Issue 10, 2013, Pages 1491-1501

  Martini, C H ^a   Yassen, A ^b   Krebs Brown, A ^b   Passier, P ^b   Stoker, M ^b   Olofsen, E ^a   Dahan, A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Astellas Pharma Global Development   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGED, 80 AND OVER; CAPSAICIN; CHRONIC PAIN; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; NEURALGIA; NEURALGIA, POSTHERPETIC; TRANSDERMAL PATCH; TREATMENT OUTCOME;

EID: 84894161846     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1002/j.1532-2149.2013.00329.x     Document Type: Article

References (23)

1. Anand, P., Bley, K. (2011). Topical capsaicin for pain management: Therapeutical potential and mechanisms of action of the new highconcentration capsaicin 8% patch. Br J Anaesth 107, 490-502.
2. Averbuch, M., Katzper, M. (2001). Gender and the placebo analgesic effect in acute pain. Clin Pharmacol Ther 70, 287-291.
3. Backonja, M., Wallace, M.S., Blonsky, E.R., Cutler, B.J., Malan, P. Jr, Rauck, R., Tobbies, J. (2008). NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: A randomized, double-blind study. Lancet Neurol 7, 1106-1112.
4. Beal, B.L., Sheiner, L.B., Boeckman, A.J., Bauer, R.J. (2009). NONMEM User's Guide (Ellicott City, MD: Icon Development Solutions)
5. Campbell, C.M., Kipnes, M.S., Stouch, B.C., Brady, K.L., Kelly, M., Schmidt, W.K., Petersen, K.L., Rowbotham, M.C., Campbell, J.N. (2012). Randomized control trial of topic clonidine for treatment of painful diabetic neuropathy. Pain 153, 1815-1823.
6. Caterina, M.J., Leffler, A., Malmberg, A.B., Martin, W.J., Trafton, J., Petersen-Zeitz, K.R., Koltzenberg, M., Basbaum, A.I., Julius, D. (2000). Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288, 306-313.
7. Caterina, M.J., Schumacher, M.A., Tominaga, M., Rosen, T.A., Levine, J.D., Julius, D. (1997). The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature 389, 816-824.
8. Dahan, A., Olofsen, E., Sigtermans, M., Noppers, I., Niesters, M., Aarts, L., Bauer, M., Sarton, E. (2011). Population pharmacokineticpharmacodynamic modeling of ketamine-induced pain relief in chronic pain. Eur J Pain 15, 258-267.
9. Eippert, F., Bingel, U., Schoell, E.D., Yacubian, J., Klinger, R., Lorenz, J., Büchel, C. (2009). Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 63, 533-543.
10. Eisenberg, E., Midbari, A., Haddad, M., Pud, D. (2010). Predicting the analgesic effect to oxycodone by 'static' and 'dynamic' quantitative sensory testing in healthy volunteers. Pain 151, 104-109.
11. Irving, G.A., Backonja, M.M., Dunteman, E., Blonsky, E.R., Vanhove, G.F., Lu, S.P., Tobias, J. (2011). A multicenter, randomized, doubleblind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia. Pain Med 12, 99-109.
12. Martini, C., Yassen, A., Olofsen, E., Passier, P., Stoker, M., Dahan, A. (2012). Pharmacodynamic analysis of the analgesic effect of capsaicin 8% patch (Qutenza™) in diabetic neuropathic pain patients: Detection of distinct response groups. J Pain Res 2, 51-59.
13. Niesters, M., Aarts, L., Sarton, E., Dahan, A. (2013). Influence of ketamine and morphine on descending pain modulation in chronic pain patients - a randomized placebo-controlled cross-over study. Br J Anaesth doi: 10.1093/bja/aes578.
14. Nolano, M., Simone, D.A., Wendelschafer-Crabb, G., Johnson, T., Hazen, E., Kennedy, W.R. (1999). Topical capsaicin in humans: Parallel loss of epidermal nerve fibers and pain sensation. Pain 81, 135-145.
15. Olofsen, E., Romberg, R., Bijl, H., Mooren, R., Engbers, F., Kest, B., Dahan, A. (2005). Alfentanil and placebo analgesia: No sex differences detected in models of experimental pain. Anesthesiology 103, 130-139.
16. Rowbotham, M.C., Petersen, K.L. (2001). Zoster-associated pain and neural dysfunction. Pain 93, 1-5.
17. Sindrup, S.H., Finnerup, N.B. (2012). Tailored treatment of peripheral neuropathic pain. Pain 153, 1781-1782.
18. Szallasi, A., Blumberg, P.M. (1999). Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 51, 159-211.
19. Tominaga, M., Caterina, M.J., Malmberg, A.B., Rosen, T.A., Gilbert, H., Skinner, K., Raumann, B.E., Basbaum, A.I., Julius, D. (1998). The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21, 531-543.
20. Watson, C.P. (2000). A new treatment for post herpetic neuralgia. N Engl J Med 343, 1563-1565.
21. Webster, L.R., Malan, T.P., Tuchman, M.M., Mollen, M.D., Tobia, J.K., Vanhove, G.F. (2010a). A multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia. J Pain 11, 972-982.
22. Webster, L.R., Tark, M., Rauck, R., Tobias, J.K., Vanhove, G.F. (2010b). Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized controlled study on NGX-1410, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia. BMC Neurol 10, 92.
23. Yarnitsky, D., Granot, M., Nahman-Averbuch, H., Khamaisi, M., Granovsky, Y. (2012). Conditioned pain modulation predicts duloxetine efficacy in painful; diabetic neuropathy. Pain 153, 1193-1196.